You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 6, 2025

Drug Price Trends for NDC 00113-0032


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00113-0032

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Drug NDC: 00113-0032

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its National Drug Code (NDC), it is crucial to understand what the NDC represents. The NDC is a unique, three-segment number that identifies a drug product. It consists of a labeler code, a product code, and a package code, which together provide a universal product identifier for human drugs[1][4].

Identifying the Drug

The NDC 00113-0032 can be broken down as follows:

  • Labeler Code: The first segment identifies the labeler, which could be a manufacturer, repackager, or relabeler.
  • Product Code: The second segment identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment identifies the package size and type.

Market Trends in the Pharmaceutical Industry

Pricing and Access

The pharmaceutical industry is facing significant challenges related to pricing and access to drugs. Nearly half of C-suite executives in the life sciences sector expect pricing and access issues to significantly impact their strategies in 2025[2].

Price Increases

Drug price increases are common in the U.S. market. From January 2022 to January 2023, over 4,200 drug products had price increases, with 46% of these increases exceeding the rate of inflation. The average price increase during this period was 15.2%, translating to an average increase of $590 per drug product[3].

Generic and Biosimilar Competition

Competition from generic drugs and biosimilars is a significant trend. With many high-revenue products facing patent expirations, the industry is bracing for substantial losses. This competition could impact the pricing strategy for branded drugs, including those identified by specific NDCs[2].

Regulatory Environment

FDA Regulations

The FDA plays a critical role in regulating drug prices and availability. The National Drug Code Directory, updated daily, contains information on all drugs manufactured, prepared, propagated, compounded, or processed for sale in the U.S. This includes data on active and certified finished and unfinished drugs, as well as compounded drug products[4].

Regulatory Changes

Regulatory changes, such as those related to the Inflation Reduction Act and potential shifts in the interpretation of laws under the Chevron doctrine, could have industry-wide implications. These changes might affect how drug prices are regulated and how companies must comply with new rules[2].

Direct-to-Consumer Market

Consumer Empowerment

Pharmaceutical companies are increasingly moving into the direct-to-consumer (DTC) market, driven by consumer empowerment and personalization. Patients are more informed and have greater control over their healthcare choices, which can influence how drugs are marketed and priced[5].

Price Projections for NDC 00113-0032

Historical Price Trends

To project future prices for the drug with NDC 00113-0032, it is essential to analyze historical price trends. If the drug has seen price increases in line with industry averages (e.g., 15.2% from January 2022 to January 2023), it is likely that future increases will follow similar patterns, adjusted for inflation and market conditions[3].

Market Competition

The presence of generic or biosimilar versions of the drug could significantly impact its pricing. If a generic or biosimilar version enters the market, the branded drug may experience a price reduction to remain competitive[2].

Regulatory Impact

Any changes in regulatory policies, such as those related to pricing controls or reimbursement structures, could also affect the price of the drug. For instance, if new regulations limit price increases or mandate discounts, this would directly impact the drug's pricing strategy[2].

Key Considerations

Affordability and Access

High prescription drug prices create affordability challenges for patients, healthcare payers, employers, and taxpayers. Any price projections must consider these challenges and the potential for regulatory or market-driven changes that could affect affordability[3].

Technological and Scientific Innovations

Advances in technology and science, such as personalized medicine and the integration of AI, can drive operational efficiencies and innovation. However, these advancements may also lead to new, potentially more expensive treatments, which could influence the pricing of existing drugs[2].

Example Scenario

If the drug identified by NDC 00113-0032 is a prescription drug with a history of price increases in line with industry averages, here is a possible scenario:

  • Historical Price: Assume the drug had a list price of $100 per unit in January 2022.
  • Price Increase: With an average increase of 15.2% from January 2022 to January 2023, the price would rise to $115.20 per unit.
  • Future Projections: If this trend continues, the price could increase by a similar percentage in subsequent years, adjusted for inflation and market conditions.

Key Takeaways

  • Regulatory Environment: Changes in FDA regulations and broader healthcare policies can significantly impact drug pricing.
  • Market Competition: The entry of generic or biosimilar versions can reduce prices of branded drugs.
  • Consumer Empowerment: Direct-to-consumer strategies can influence how drugs are marketed and priced.
  • Technological Advancements: Innovations in technology and science can drive operational efficiencies but may also lead to new, potentially more expensive treatments.

FAQs

Q: What is the National Drug Code (NDC) and how is it used? A: The NDC is a unique, three-segment number that identifies a drug product. It includes a labeler code, a product code, and a package code, and is used by the FDA to track and regulate drug products[1][4].

Q: How often are drug prices increased in the U.S.? A: Drug price increases are quite common, with over 4,200 drug products experiencing price increases from January 2022 to January 2023. The average increase during this period was 15.2%[3].

Q: What impact do generic and biosimilar drugs have on branded drug prices? A: The entry of generic or biosimilar versions can significantly reduce the prices of branded drugs as they provide cheaper alternatives, increasing competition in the market[2].

Q: How does the FDA regulate drug prices and availability? A: The FDA regulates drug prices and availability through various mechanisms, including the National Drug Code Directory and compliance with the Drug Listing Act. Regulatory changes can also impact pricing strategies[1][4].

Q: What role does consumer empowerment play in drug pricing and marketing? A: Consumer empowerment, driven by increased access to information and personalization, is leading pharmaceutical companies to adopt direct-to-consumer strategies, which can influence how drugs are marketed and priced[5].

Sources

  1. FDA: National Drug Code Database Background Information - FDA
  2. Deloitte Insights: 2025 life sciences outlook
  3. ASPE: Changes in the List Prices of Prescription Drugs, 2017-2023
  4. FDA: National Drug Code Directory
  5. Definitive Healthcare: 2025 Life Science Trends: Pharma Goes DTC

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.